These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 30868554
1. β3 -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions? Igawa Y, Aizawa N, Michel MC. Br J Pharmacol; 2019 Jul; 176(14):2525-2538. PubMed ID: 30868554 [Abstract] [Full Text] [Related]
2. Agonist-induced desensitisation of β3 -adrenoceptors: Where, when, and how? Okeke K, Angers S, Bouvier M, Michel MC. Br J Pharmacol; 2019 Jul; 176(14):2539-2558. PubMed ID: 30809805 [Abstract] [Full Text] [Related]
3. Mirabegron: potential off target effects and uses beyond the bladder. Dehvari N, da Silva Junior ED, Bengtsson T, Hutchinson DS. Br J Pharmacol; 2018 Nov; 175(21):4072-4082. PubMed ID: 29243229 [Abstract] [Full Text] [Related]
4. Inhibition of cholinergic neurotransmission by β3-adrenoceptors depends on adenosine release and A1-receptor activation in human and rat urinary bladders. Silva I, Costa AF, Moreira S, Ferreirinha F, Magalhães-Cardoso MT, Calejo I, Silva-Ramos M, Correia-de-Sá P. Am J Physiol Renal Physiol; 2017 Aug 01; 313(2):F388-F403. PubMed ID: 28446460 [Abstract] [Full Text] [Related]
5. Modulation of nerve-evoked contractions by β3-adrenoceptor agonism in human and rat isolated urinary bladder. Rouget C, Rekik M, Camparo P, Botto H, Rischmann P, Lluel P, Palea S, Westfall TD. Pharmacol Res; 2014 Feb 01; 80():14-20. PubMed ID: 24378642 [Abstract] [Full Text] [Related]
6. Involvement of β3-adrenoceptors in the inhibitory control of cholinergic activity in human bladder: Direct evidence by [(3)H]-acetylcholine release experiments in the isolated detrusor. D' Agostino G, Maria Condino A, Calvi P. Eur J Pharmacol; 2015 Jul 05; 758():115-22. PubMed ID: 25861936 [Abstract] [Full Text] [Related]
7. Investigations into the presence of functional Beta1, Beta2 and Beta3-adrenoceptors in urothelium and detrusor of human bladder. Tyagi P, Thomas CA, Yoshimura N, Chancellor MB. Int Braz J Urol; 2009 Jul 05; 35(1):76-83. PubMed ID: 19254402 [Abstract] [Full Text] [Related]
8. Pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in cynomolgus monkeys. Hatanaka T, Ukai M, Watanabe M, Someya A, Ohtake A, Suzuki M, Ueshima K, Sato S, Masuda N. Naunyn Schmiedebergs Arch Pharmacol; 2013 Nov 05; 386(11):1001-8. PubMed ID: 23832377 [Abstract] [Full Text] [Related]
9. In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats. Hatanaka T, Ukai M, Watanabe M, Someya A, Ohtake A, Suzuki M, Ueshima K, Sato S, Sasamata M. Naunyn Schmiedebergs Arch Pharmacol; 2013 Mar 05; 386(3):247-53. PubMed ID: 23239087 [Abstract] [Full Text] [Related]
10. The novel β3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity. Svalø J, Nordling J, Bouchelouche K, Andersson KE, Korstanje C, Bouchelouche P. Eur J Pharmacol; 2013 Jan 15; 699(1-3):101-5. PubMed ID: 23246623 [Abstract] [Full Text] [Related]
11. Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder? Michel MC. Naunyn Schmiedebergs Arch Pharmacol; 2014 Mar 15; 387(3):215-24. PubMed ID: 24213882 [Abstract] [Full Text] [Related]
12. β3-Adrenoceptor agonists inhibit purinergic receptor-mediated contractions of the murine detrusor. Fong Z, Griffin CS, Hollywood MA, Thornbury KD, Sergeant GP. Am J Physiol Cell Physiol; 2019 Jul 01; 317(1):C131-C142. PubMed ID: 31042424 [Abstract] [Full Text] [Related]
13. The β3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome. Masunaga K, Chapple CR, McKay NG, Yoshida M, Sellers DJ. Neurourol Urodyn; 2010 Sep 01; 29(7):1320-5. PubMed ID: 20151470 [Abstract] [Full Text] [Related]
14. Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade. Alexandre EC, Kiguti LR, Calmasini FB, Silva FH, da Silva KP, Ferreira R, Ribeiro CA, Mónica FZ, Pupo AS, Antunes E. Br J Pharmacol; 2016 Feb 01; 173(3):415-28. PubMed ID: 26493129 [Abstract] [Full Text] [Related]
15. A functional analysis of the influence of β3-adrenoceptors on the rat micturition cycle. Sadananda P, Drake MJ, Paton JF, Pickering AE. J Pharmacol Exp Ther; 2013 Nov 01; 347(2):506-15. PubMed ID: 24008334 [Abstract] [Full Text] [Related]
16. Involvement of beta(3)-adrenoceptors in mouse urinary bladder function: role in detrusor muscle relaxation and micturition reflex. Deba A, Palea S, Rouget C, Westfall TD, Lluel P. Eur J Pharmacol; 2009 Sep 15; 618(1-3):76-83. PubMed ID: 19619525 [Abstract] [Full Text] [Related]
17. β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β3 -adrenoceptors. Dal Monte M, Calvani M, Cammalleri M, Favre C, Filippi L, Bagnoli P. Br J Pharmacol; 2019 Jul 15; 176(14):2496-2508. PubMed ID: 30471093 [Abstract] [Full Text] [Related]
18. Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. Otsuka A, Shinbo H, Matsumoto R, Kurita Y, Ozono S. Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun 15; 377(4-6):473-81. PubMed ID: 18311486 [Abstract] [Full Text] [Related]
19. Protective effect of a β3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia. Sawada N, Nomiya M, Hood B, Koslov D, Zarifpour M, Andersson KE. Eur Urol; 2013 Oct 15; 64(4):664-71. PubMed ID: 23838637 [Abstract] [Full Text] [Related]